SciVision Biotech Inc (1786.TW) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Taiwan · ISIN TW0001786002
SciVision Biotech Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 883.31 m TWD | 886.62 m TWD |
| Gross profit | 655.68 m TWD | 638.39 m TWD |
| Operating income | 248.11 m TWD | 189.92 m TWD |
| EBIT | 297.27 m TWD | 189.78 m TWD |
| Net income | 242.25 m TWD | 162.34 m TWD |
| Diluted EPS – continuing operations | 3.25 TWD | 2.24 TWD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SciVision Biotech Inc
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
More stocks
- Rare Earths Americas, Inc. (REA)
- Atomera Inc (ATOM)
- Yunsung F&C Co. Ltd. (372170.KQ)
- DAEYANG ELECTRIC.Co.Ltd (108380.KQ)
- Falco Resources Ltd (FPC.V)
- Cheffelo AB (CHEF.ST)
- UNION BANKSHARES INC (UNB)
- McRae Industries Inc (MCRAB)
- Sunko Ink Co Ltd (1721.TW)
- Yellow Pages Limited (Y.TO)
- Black Mammoth Metals Corp (BMM.V)
- Draganfly Inc (DPRO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.